Veraxa Biotech (VRXA) director Marc Gruninger files initial insider Form 3
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Veraxa Biotech Holding AG director Marc Gruninger filed an initial Form 3, which is a statement of beneficial ownership for company insiders. This filing does not list any stock transactions or holdings details; it simply establishes him as a reporting insider for future ownership and trading disclosures.
Positive
- None.
Negative
- None.
Key Terms
Form 3, beneficial ownership, reporting person
3 terms
Form 3 regulatory
"Marc Gruninger filed an initial Form 3, which is a statement of beneficial ownership"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
beneficial ownership financial
"Form 3, which is a statement of beneficial ownership for company insiders"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
reporting person regulatory
"It simply establishes him as a reporting insider for future ownership and trading disclosures"
FAQ
What does the Veraxa Biotech (VRXA) Form 3 filing for Marc Gruninger show?
The Form 3 shows that Marc Gruninger is a director and now an insider reporting person at Veraxa Biotech Holding AG. It is an initial ownership report and does not list any specific stock transactions or share amounts.
Are there any stock purchases or sales in the Veraxa Biotech (VRXA) Form 3?
No, this Form 3 contains no reported stock purchases, sales, or other transactions. It only identifies Marc Gruninger as a director and sets up his status for future insider ownership and trading disclosures with the SEC.
Why is Marc Gruninger listed as a reporting person for Veraxa Biotech (VRXA)?
Marc Gruninger is listed as a reporting person because he serves as a director at Veraxa Biotech Holding AG. Directors are considered insiders and must file Form 3 to begin formally reporting their beneficial ownership and future changes in their holdings.
How does this Veraxa Biotech (VRXA) Form 3 affect investors?
This Form 3 mainly provides administrative transparency by identifying Marc Gruninger as an insider director. It does not report any trades or ownership changes, but it means future insider transactions by him will be reported on subsequent SEC forms.